Copyright © IMARC Service Pvt Ltd. All Rights Reserved Global Artificial Pancreas Device Systems (APDS) Market Research Report 2022-2027 Author: Elena Anderson Marketing Manager IMARC Group© IMARC All Rights Reserved
Report DescriptionAbout IMARC Group
International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Artificial Pancreas Device Systems (APDS) Market Outlook 2022-2027:
According to the latest report by IMARC Group, titled "Artificial Pancreas Device Systems (APDS) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 20222027," the global artificial pancreas device systems market reached a value of US$ 1,949 Million in 2021. Artificial pancreas device systems (APDS) refer to a diabetes management system that is designed to regulate blood glucose levels in the human body. These systems mimic the functioning of a healthy pancreas with the help of a continuous glucose monitor (CGM) and an insulin infusion pump. The CGM, along with a sensor that is subcutaneously placed under the patient's skin, is utilized to track blood glucose levels and to determine the required insulin level of the body by evaluating realtime glucose readings. In case insulin deficit is registered by the CGM, the computer-controlled algorithm of the system sends an alert to the infusion pump that delivers the appropriate amount of insulin required by the body throughout the day in controlled amounts.
Report Report Description and Highlights
Request for a PDF sample of this report: https://www.imarcgroup.com/artificial-pancreas-devicesystems-market/requestsample
Description
The global market is primarily driven by the rising prevalence of several lifestyle disorders, such as obesity and diabetes. This is further facilitated by the confluence of numerous factors, including a lack of physical activities and shifting dietary preferences. Consequently, there has been a significant increase in the demand for efficient glucose monitoring solutions, which is providing a thrust to the uptake of APDS. These systems offer flexibility, rapid action and enhanced convenience to the users, which has contributed to their widespread preference among masses. Continual innovations and extensive research and development (R&D) activities have led to the introduction of software-based wireless systems that are equipped with automated controls, which is acting as another major growth-inducing factor. The market is further driven by the development of versatile devices that are integrated with advanced technologies. For instance, Beta Bionics, a Massachusetts-based company, received breakthrough device designation from the Food and Drug Administration (US FDA) in the United States for developing its iLet Bionics Pancreas System that functions as three medical devices in one: as an insulin-only bionic pancreas, a glucagon-only bionic pancreas or a bihormonal bionic pancreas using insulin and glucagon.
Report Description Report Description and Highlights
Global Artificial Pancreas Device Systems (APDS) Market Drivers:
Report Description Report Description and Highlights The system employs artificial intelligence (AI) and machine learning that aids in understanding the changing insulin needs of the patient. On account of the aforementioned factors, the market is expected to grow at a CAGR of 13.4% during View2022-2027.Report TOC, Figures and Tables: https://www.imarcgroup.com/artificial-pancreas-devicesystems-market
Report Description Report Description and Highlights Key Market Segmentation The research report includes the following segments: Breakup by Device Type: • Threshold Suspend Device Systems • Control-to-Range Systems • Control-to-Target Systems Breakup by Treatment Type: • Bi-hormonal • Insulin Only • Hybrid
Report Description Report Description and Highlights Breakup by End-User: • Hospitals • Medical Centres • Others Breakup by Region: • Europe • North America • Asia Pacific • Middle East and Africa • Latin America Note: We are updating our reports, If you want the report with the latest primary and secondary data (2022-2027) including industry trends, market size and Competitive landscape, etc. click here: https://www.imarcgroup.com/request?type=report&id=1918&flag=C
Report Description Report Description and Highlights Competitive Landscape: • Beta Bionics Inc. • Bigfoot Biomedical Inc. • Dexcom Inc. • Inreda Diabetic B.V. • Insulet Corporation • Johnson & Johnson • Medtronic Inc. • F. Hoffmann-La Roche Ltd • Tandem Diabetes Care Inc.
Report Description Key Questions Answered in the Report 1. How has the global artificial pancreas device systems market performed so far and how will it perform in the coming years? 2. What are the key regional markets? 3. What has been the impact of COVID-19 on the global artificial pancreas device systems market? 4. What is the breakup of the market based on the device type? 5. What is the breakup of the market based on the treatment type? 6. What is the breakup of the market based on the end-user? 7. What are the various stages in the value chain of the industry? 8. What are the key driving factors and challenges in the industry? 9. What is the structure of the global artificial pancreas device systems market and who are the key players? 10. What is the degree of competition in the industry?
Report Description Table of Contents 1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources. 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends
Report Description Table of Contents 5 Global Artificial Pancreas Device Systems Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Device Type 6.1 Threshold Suspend Device Systems 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Control-to-Range Systems 6.2.1 Market Trends 6.2.2 Market Forecast Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/artificial-pancreas-device-systems-market/toc
A partial List of our Clients We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients
A partial List of our Clients We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients
Report Description Report Description and Highlights © 2022 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
FOR MORE DETAILS Visit us at : Stay With Us: TELEPHONE: +1-631-791-1145 -MAIL: sales@imarcgroup.com https://www.imarcgroup.com Contact Us
